EUVIMEDEUVIMED entdecken
Crossref

Selective orexin 1 receptor antagonism does not affect effort-based responding for sucrose reward in rats

Giorgio Bergamini, Sean Durkin, Michel Alexander Steiner iD

Journal of Psychopharmacology · 2024

DOI: 10.1177/02698811241229523 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Psychopharmacology, 2024. Verfasst von Giorgio Bergamini und 2 weiteren Autor:innen. Beteiligte Einrichtung: CNS Pharmacology, Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland. Hauptthemen laut MEDLINE: Sucrose, Reward, Benzoxazoles, Naphthyridines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 10 Literaturangaben. Gefördert von: Idorsia Pharmaceuticals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In rodents, orexin neuropeptides regulate motivation and reward-seeking via orexin 1 receptor (OX1R) signaling in the mesolimbic dopaminergic system. This role is clearly established for rewards inherent to drugs of abuse but less so for natural rewards. Reported effects of the selective OX1R antagonist (SO1RA) SB-334867 on motivation for palatable food are ambiguous. In our experimental conditions neither SB-334867, nor two additional, structurally different SO1RAs, ACT-335827 and the clinical development candidate nivasorexant, affected effort-based responding for sucrose in rats. The positive control lisdexamfetamine, approved for psychiatric disorders associated with altered reward sensitivity such as binge eating disorder, increased effort-based responding.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SucroseRewardBenzoxazolesNaphthyridinesHumansRatsAnimalsOrexinsOrexin ReceptorsConditioning, OperantUrea

Stichwörter der Autor:innen

Orexinbinge eatingmotivationoperant testingprogressive ratio testratsselective orexin 1 receptor antagonist

Substanzen

Orexins1-(2-methylbenzoxazol-6-yl)-3-(1,5)naphthyridin-4-yl ureaOrexin ReceptorsSucroseBenzoxazolesNaphthyridinesUrea

Autor:innen und Institutionen

  • CNS Pharmacology, Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland.

ORCID-Profile: Michel Alexander Steiner

Förderung

  • Idorsia Pharmaceuticals

Zitieren

APA

Bergamini, G., Durkin, S., & Steiner, M. A. (2024). Selective orexin 1 receptor antagonism does not affect effort-based responding for sucrose reward in rats. Journal of Psychopharmacology. https://doi.org/10.1177/02698811241229523

Vancouver

Bergamini G, Durkin S, Steiner MA. Selective orexin 1 receptor antagonism does not affect effort-based responding for sucrose reward in rats. Journal of Psychopharmacology. 2024. doi:10.1177/02698811241229523

BibTeX
@article{Bergamini2024,
  author = {Bergamini, Giorgio and Durkin, Sean and Steiner, Michel Alexander},
  title = {Selective orexin 1 receptor antagonism does not affect effort-based responding for sucrose reward in rats},
  journal = {Journal of Psychopharmacology},
  year = {2024},
  doi = {10.1177/02698811241229523}
}
Kostenlos starten →